Zhuhai Sailong Pharmaceutical Co Ltd
Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pan… Read more
Zhuhai Sailong Pharmaceutical Co Ltd (002898) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.062x
Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a cash flow conversion efficiency ratio of -0.062x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-28.66 Million) by net assets (CN¥460.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhuhai Sailong Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Molong Petroleum Machinery Company Limited
PINK:SHANY
|
N/A |
|
K.P. Energy Limited
NSE:KPEL
|
N/A |
|
PROQR THERAPEUTICS EO-04
F:0PQ
|
N/A |
|
Impact Develop
RO:IMP
|
0.005x |
|
Orthocell Ltd
AU:OCC
|
-0.211x |
|
Syscom Computer Engineering Co
TW:2453
|
-0.212x |
|
MicroPort CardioFlow Medtech Corporation
PINK:MROPF
|
N/A |
|
X-Legend Entertainment Co Ltd
TW:4994
|
0.030x |
Annual Cash Flow Conversion Efficiency for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥499.28 Million | CN¥-38.86 Million | -0.078x | -216.81% |
| 2023-12-31 | CN¥535.88 Million | CN¥35.71 Million | 0.067x | +148.30% |
| 2022-12-31 | CN¥526.35 Million | CN¥14.12 Million | 0.027x | -57.35% |
| 2021-12-31 | CN¥563.66 Million | CN¥35.46 Million | 0.063x | +21040.16% |
| 2020-12-31 | CN¥587.00 Million | CN¥174.69K | 0.000x | +100.42% |
| 2019-12-31 | CN¥659.02 Million | CN¥-46.52 Million | -0.071x | -1507.08% |
| 2018-12-31 | CN¥663.54 Million | CN¥3.33 Million | 0.005x | -96.35% |
| 2017-12-31 | CN¥618.64 Million | CN¥85.13 Million | 0.138x | -55.48% |
| 2016-12-31 | CN¥254.45 Million | CN¥78.65 Million | 0.309x | +38.92% |
| 2015-12-31 | CN¥213.20 Million | CN¥47.44 Million | 0.223x | -39.11% |
| 2014-12-31 | CN¥140.55 Million | CN¥51.36 Million | 0.365x | -36.90% |
| 2013-12-31 | CN¥111.97 Million | CN¥64.84 Million | 0.579x | -- |